Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
J. Morganroth
,
E. Neil Moore
Details
OL Work ID
OL23655697W
Find this book
Open Library